Compile Data Set for Download or QSAR
Report error Found 142 Enz. Inhib. hit(s) with all data for entry = 10083
TargetSerine hydroxymethyltransferase, mitochondrial [30-504](Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512948BDBM512948(US11091451, Compound I-16)
Affinity DataIC50: 1.00E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, mitochondrial [30-504](Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512949BDBM512949(US11091451, Compound I-17)
Affinity DataIC50: 1.00E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, mitochondrial [30-504](Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512950BDBM512950(US11091451, Compound I-18)
Affinity DataIC50: 1.00E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, mitochondrial [30-504](Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512952BDBM512952(US11091451, Compound I-19)
Affinity DataIC50: 1.00E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, mitochondrial [30-504](Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512954BDBM512954(US11091451, Compound I-20)
Affinity DataIC50: 1.00E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, mitochondrial [30-504](Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512955BDBM512955(US11091451, Compound I-21)
Affinity DataIC50: 1.00E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, mitochondrial [30-504](Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512956BDBM512956(US11091451, Compound I-22)
Affinity DataIC50: 1.00E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, mitochondrial [30-504](Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512936BDBM512936(US11091451, Compound I-8)
Affinity DataIC50: 1.00E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, cytosolic(Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512937BDBM512937(US11091451, Compound I-9)
Affinity DataIC50: 1.00E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, mitochondrial [30-504](Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512937BDBM512937(US11091451, Compound I-9)
Affinity DataIC50: 1.00E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, cytosolic(Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512938BDBM512938(US11091451, Compound I-10)
Affinity DataIC50: 1.00E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, mitochondrial [30-504](Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512938BDBM512938(US11091451, Compound I-10)
Affinity DataIC50: 1.00E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, mitochondrial [30-504](Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512939BDBM512939(US11091451, Compound I-11)
Affinity DataIC50: 1.00E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, mitochondrial [30-504](Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512941BDBM512941(US11091451, Compound I-12)
Affinity DataIC50: 1.00E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, mitochondrial [30-504](Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512943BDBM512943(US11091451, Compound I-13)
Affinity DataIC50: 1.00E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, mitochondrial [30-504](Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512944BDBM512944(US11091451, Compound I-14)
Affinity DataIC50: 1.00E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, mitochondrial [30-504](Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512945BDBM512945(US11091451, Compound I-15)
Affinity DataIC50: 1.00E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, cytosolic(Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512917BDBM512917(US11091451, Compound I-1)
Affinity DataIC50: 1.00E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, mitochondrial [30-504](Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512917BDBM512917(US11091451, Compound I-1)
Affinity DataIC50: 1.00E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, cytosolic(Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512921BDBM512921(US11091451, Compound I-2)
Affinity DataIC50: 1.00E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, cytosolic(Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512923BDBM512923(US11091451, Compound I-3)
Affinity DataIC50: 1.00E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, mitochondrial [30-504](Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512923BDBM512923(US11091451, Compound I-3)
Affinity DataIC50: 1.00E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, cytosolic(Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512925BDBM512925(US11091451, Compound I-4)
Affinity DataIC50: 1.00E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, mitochondrial [30-504](Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512925BDBM512925(US11091451, Compound I-4)
Affinity DataIC50: 1.00E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, cytosolic(Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512926BDBM512926(US11091451, Compound I-5)
Affinity DataIC50: 1.00E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, mitochondrial [30-504](Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512926BDBM512926(US11091451, Compound I-5)
Affinity DataIC50: 1.00E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, cytosolic(Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512928BDBM512928(US11091451, Compound I-6)
Affinity DataIC50: 1.00E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, mitochondrial [30-504](Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512928BDBM512928(US11091451, Compound I-6)
Affinity DataIC50: 1.00E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, cytosolic(Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512933BDBM512933(US11091451, Compound I-7)
Affinity DataIC50: 1.00E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, mitochondrial [30-504](Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512933BDBM512933(US11091451, Compound I-7)
Affinity DataIC50: 1.00E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, cytosolic(Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512936BDBM512936(US11091451, Compound I-8)
Affinity DataIC50: 1.00E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, mitochondrial [30-504](Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512958BDBM512958(US11091451, Compound I-24)
Affinity DataIC50: 1.00E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, mitochondrial [30-504](Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512960BDBM512960(US11091451, Compound I-25)
Affinity DataIC50: 1.00E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, cytosolic(Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512949BDBM512949(US11091451, Compound I-17)
Affinity DataIC50: 5.50E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, cytosolic(Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512950BDBM512950(US11091451, Compound I-18)
Affinity DataIC50: 5.50E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, cytosolic(Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512952BDBM512952(US11091451, Compound I-19)
Affinity DataIC50: 5.50E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, cytosolic(Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512954BDBM512954(US11091451, Compound I-20)
Affinity DataIC50: 5.50E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, cytosolic(Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512955BDBM512955(US11091451, Compound I-21)
Affinity DataIC50: 5.50E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, cytosolic(Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512956BDBM512956(US11091451, Compound I-22)
Affinity DataIC50: 5.50E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, cytosolic(Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512957BDBM512957(US11091451, Compound I-23)
Affinity DataIC50: 5.50E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, mitochondrial [30-504](Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512957BDBM512957(US11091451, Compound I-23)
Affinity DataIC50: 5.50E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, cytosolic(Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512958BDBM512958(US11091451, Compound I-24)
Affinity DataIC50: 5.50E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, cytosolic(Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512939BDBM512939(US11091451, Compound I-11)
Affinity DataIC50: 5.50E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, cytosolic(Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512941BDBM512941(US11091451, Compound I-12)
Affinity DataIC50: 5.50E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, cytosolic(Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512943BDBM512943(US11091451, Compound I-13)
Affinity DataIC50: 5.50E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, cytosolic(Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512944BDBM512944(US11091451, Compound I-14)
Affinity DataIC50: 5.50E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, cytosolic(Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512945BDBM512945(US11091451, Compound I-15)
Affinity DataIC50: 5.50E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, cytosolic(Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512948BDBM512948(US11091451, Compound I-16)
Affinity DataIC50: 5.50E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, mitochondrial [30-504](Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512973BDBM512973(US11091451, Compound I-33)
Affinity DataIC50: 5.50E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

TargetSerine hydroxymethyltransferase, mitochondrial [30-504](Human)
Raze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 512921BDBM512921(US11091451, Compound I-2)
Affinity DataIC50: 5.50E+3nMAssay Description:Full length human cytosolic Serine Hydroxymethyl transferase 1 (SHMT1, residues 1-483 in Uniport ID P34896) was expressed as an N-terminal His6 tagge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
US Patent

Displayed 1 to 50 (of 142 total ) | Next | Last >>
Jump to: